Using rich experimental data on household treatment- seeking behavior in Kenya, this study explores the implications of the over-treatment vs. under-treatment trade-off for subsidizing life-saving antimalarials sold over-the-counter at retail drug outlets. The results of this study show that a very high subsidy (such as the one under consideration by the international community) dramatically increases access, but nearly one-half of subsidized pills go to patients without malaria.
Author: Cohen J, Dupas P, Schaner S
Publication date: February 2015
Source: American Economic Review